0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global ADC Drug CDMO Service Market Research Report 2024
Published Date: September 2024
|
Report Code: QYRE-Auto-21U18281
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global ADC Drug CDMO Service Market Research Report 2024
BUY CHAPTERS

Global ADC Drug CDMO Service Market Research Report 2024

Code: QYRE-Auto-21U18281
Report
September 2024
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

ADC Drug CDMO Service Market

ADC drugs, also known as antibody drug coupling agents, work by coupling small molecule drugs with antibodies through linkers to form drugs. These drugs combine the high targeting ability of antibodies with the strong killing power of chemical drugs, and are considered the most promising next-generation antibody technology. To reduce research and development costs, most ADC drug development worldwide chooses outsourcing, leveraging CDMO companies to enter clinical and market more quickly. CDMO services refer to pharmaceutical and biotechnology companies outsourcing the research and production of their drugs or biological products to professional CDMO companies. These CDMO companies provide a range of services, including but not limited to drug synthesis, chemical and biological analysis, formulation development, clinical production, and commercial production. The core of CDMO services lies in its ability to customize and specialize, which can meet the specific needs of different customers at different stages.
The global ADC Drug CDMO Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for ADC Drug CDMO Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for ADC Drug CDMO Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for ADC Drug CDMO Service in Small and Medium-sized Pharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of ADC Drug CDMO Service include WuXi XDC, Lonza, Merck, Axplora, Catalent, Abbvie, MabPlex International, TOT Biopharm, Zencore Biologics, Healsun Biopharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for ADC Drug CDMO Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ADC Drug CDMO Service.
The ADC Drug CDMO Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global ADC Drug CDMO Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ADC Drug CDMO Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of ADC Drug CDMO Service Market Report

Report Metric Details
Report Name ADC Drug CDMO Service Market
Segment by Type
  • Antibody
  • Linker and Payload
  • Other
Segment by Application
  • Small and Medium-sized Pharmaceutical Companies
  • Large Pharmaceutical Companies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company WuXi XDC, Lonza, Merck, Axplora, Catalent, Abbvie, MabPlex International, TOT Biopharm, Zencore Biologics, Healsun Biopharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of ADC Drug CDMO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the ADC Drug CDMO Service Market report?

Ans: The main players in the ADC Drug CDMO Service Market are WuXi XDC, Lonza, Merck, Axplora, Catalent, Abbvie, MabPlex International, TOT Biopharm, Zencore Biologics, Healsun Biopharm

What are the Application segmentation covered in the ADC Drug CDMO Service Market report?

Ans: The Applications covered in the ADC Drug CDMO Service Market report are Small and Medium-sized Pharmaceutical Companies, Large Pharmaceutical Companies

What are the Type segmentation covered in the ADC Drug CDMO Service Market report?

Ans: The Types covered in the ADC Drug CDMO Service Market report are Antibody, Linker and Payload, Other

Recommended Reports

CDMO Market Services

ADC & Biologic CDMO

Small Molecule CDMO

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ADC Drug CDMO Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibody
1.2.3 Linker and Payload
1.2.4 Other
1.3 Market by Application
1.3.1 Global ADC Drug CDMO Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Small and Medium-sized Pharmaceutical Companies
1.3.3 Large Pharmaceutical Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global ADC Drug CDMO Service Market Perspective (2019-2030)
2.2 Global ADC Drug CDMO Service Growth Trends by Region
2.2.1 Global ADC Drug CDMO Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 ADC Drug CDMO Service Historic Market Size by Region (2019-2024)
2.2.3 ADC Drug CDMO Service Forecasted Market Size by Region (2025-2030)
2.3 ADC Drug CDMO Service Market Dynamics
2.3.1 ADC Drug CDMO Service Industry Trends
2.3.2 ADC Drug CDMO Service Market Drivers
2.3.3 ADC Drug CDMO Service Market Challenges
2.3.4 ADC Drug CDMO Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top ADC Drug CDMO Service Players by Revenue
3.1.1 Global Top ADC Drug CDMO Service Players by Revenue (2019-2024)
3.1.2 Global ADC Drug CDMO Service Revenue Market Share by Players (2019-2024)
3.2 Global ADC Drug CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by ADC Drug CDMO Service Revenue
3.4 Global ADC Drug CDMO Service Market Concentration Ratio
3.4.1 Global ADC Drug CDMO Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ADC Drug CDMO Service Revenue in 2023
3.5 Global Key Players of ADC Drug CDMO Service Head office and Area Served
3.6 Global Key Players of ADC Drug CDMO Service, Product and Application
3.7 Global Key Players of ADC Drug CDMO Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 ADC Drug CDMO Service Breakdown Data by Type
4.1 Global ADC Drug CDMO Service Historic Market Size by Type (2019-2024)
4.2 Global ADC Drug CDMO Service Forecasted Market Size by Type (2025-2030)
5 ADC Drug CDMO Service Breakdown Data by Application
5.1 Global ADC Drug CDMO Service Historic Market Size by Application (2019-2024)
5.2 Global ADC Drug CDMO Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America ADC Drug CDMO Service Market Size (2019-2030)
6.2 North America ADC Drug CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America ADC Drug CDMO Service Market Size by Country (2019-2024)
6.4 North America ADC Drug CDMO Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe ADC Drug CDMO Service Market Size (2019-2030)
7.2 Europe ADC Drug CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe ADC Drug CDMO Service Market Size by Country (2019-2024)
7.4 Europe ADC Drug CDMO Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific ADC Drug CDMO Service Market Size (2019-2030)
8.2 Asia-Pacific ADC Drug CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific ADC Drug CDMO Service Market Size by Region (2019-2024)
8.4 Asia-Pacific ADC Drug CDMO Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America ADC Drug CDMO Service Market Size (2019-2030)
9.2 Latin America ADC Drug CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America ADC Drug CDMO Service Market Size by Country (2019-2024)
9.4 Latin America ADC Drug CDMO Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa ADC Drug CDMO Service Market Size (2019-2030)
10.2 Middle East & Africa ADC Drug CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa ADC Drug CDMO Service Market Size by Country (2019-2024)
10.4 Middle East & Africa ADC Drug CDMO Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 WuXi XDC
11.1.1 WuXi XDC Company Details
11.1.2 WuXi XDC Business Overview
11.1.3 WuXi XDC ADC Drug CDMO Service Introduction
11.1.4 WuXi XDC Revenue in ADC Drug CDMO Service Business (2019-2024)
11.1.5 WuXi XDC Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza ADC Drug CDMO Service Introduction
11.2.4 Lonza Revenue in ADC Drug CDMO Service Business (2019-2024)
11.2.5 Lonza Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck ADC Drug CDMO Service Introduction
11.3.4 Merck Revenue in ADC Drug CDMO Service Business (2019-2024)
11.3.5 Merck Recent Development
11.4 Axplora
11.4.1 Axplora Company Details
11.4.2 Axplora Business Overview
11.4.3 Axplora ADC Drug CDMO Service Introduction
11.4.4 Axplora Revenue in ADC Drug CDMO Service Business (2019-2024)
11.4.5 Axplora Recent Development
11.5 Catalent
11.5.1 Catalent Company Details
11.5.2 Catalent Business Overview
11.5.3 Catalent ADC Drug CDMO Service Introduction
11.5.4 Catalent Revenue in ADC Drug CDMO Service Business (2019-2024)
11.5.5 Catalent Recent Development
11.6 Abbvie
11.6.1 Abbvie Company Details
11.6.2 Abbvie Business Overview
11.6.3 Abbvie ADC Drug CDMO Service Introduction
11.6.4 Abbvie Revenue in ADC Drug CDMO Service Business (2019-2024)
11.6.5 Abbvie Recent Development
11.7 MabPlex International
11.7.1 MabPlex International Company Details
11.7.2 MabPlex International Business Overview
11.7.3 MabPlex International ADC Drug CDMO Service Introduction
11.7.4 MabPlex International Revenue in ADC Drug CDMO Service Business (2019-2024)
11.7.5 MabPlex International Recent Development
11.8 TOT Biopharm
11.8.1 TOT Biopharm Company Details
11.8.2 TOT Biopharm Business Overview
11.8.3 TOT Biopharm ADC Drug CDMO Service Introduction
11.8.4 TOT Biopharm Revenue in ADC Drug CDMO Service Business (2019-2024)
11.8.5 TOT Biopharm Recent Development
11.9 Zencore Biologics
11.9.1 Zencore Biologics Company Details
11.9.2 Zencore Biologics Business Overview
11.9.3 Zencore Biologics ADC Drug CDMO Service Introduction
11.9.4 Zencore Biologics Revenue in ADC Drug CDMO Service Business (2019-2024)
11.9.5 Zencore Biologics Recent Development
11.10 Healsun Biopharm
11.10.1 Healsun Biopharm Company Details
11.10.2 Healsun Biopharm Business Overview
11.10.3 Healsun Biopharm ADC Drug CDMO Service Introduction
11.10.4 Healsun Biopharm Revenue in ADC Drug CDMO Service Business (2019-2024)
11.10.5 Healsun Biopharm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global ADC Drug CDMO Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Antibody
 Table 3. Key Players of Linker and Payload
 Table 4. Key Players of Other
 Table 5. Global ADC Drug CDMO Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global ADC Drug CDMO Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global ADC Drug CDMO Service Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global ADC Drug CDMO Service Market Share by Region (2019-2024)
 Table 9. Global ADC Drug CDMO Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global ADC Drug CDMO Service Market Share by Region (2025-2030)
 Table 11. ADC Drug CDMO Service Market Trends
 Table 12. ADC Drug CDMO Service Market Drivers
 Table 13. ADC Drug CDMO Service Market Challenges
 Table 14. ADC Drug CDMO Service Market Restraints
 Table 15. Global ADC Drug CDMO Service Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global ADC Drug CDMO Service Market Share by Players (2019-2024)
 Table 17. Global Top ADC Drug CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADC Drug CDMO Service as of 2023)
 Table 18. Ranking of Global Top ADC Drug CDMO Service Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by ADC Drug CDMO Service Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of ADC Drug CDMO Service, Headquarters and Area Served
 Table 21. Global Key Players of ADC Drug CDMO Service, Product and Application
 Table 22. Global Key Players of ADC Drug CDMO Service, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global ADC Drug CDMO Service Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global ADC Drug CDMO Service Revenue Market Share by Type (2019-2024)
 Table 26. Global ADC Drug CDMO Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global ADC Drug CDMO Service Revenue Market Share by Type (2025-2030)
 Table 28. Global ADC Drug CDMO Service Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global ADC Drug CDMO Service Revenue Market Share by Application (2019-2024)
 Table 30. Global ADC Drug CDMO Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global ADC Drug CDMO Service Revenue Market Share by Application (2025-2030)
 Table 32. North America ADC Drug CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America ADC Drug CDMO Service Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America ADC Drug CDMO Service Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe ADC Drug CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe ADC Drug CDMO Service Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe ADC Drug CDMO Service Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific ADC Drug CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific ADC Drug CDMO Service Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific ADC Drug CDMO Service Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America ADC Drug CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America ADC Drug CDMO Service Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America ADC Drug CDMO Service Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa ADC Drug CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa ADC Drug CDMO Service Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa ADC Drug CDMO Service Market Size by Country (2025-2030) & (US$ Million)
 Table 47. WuXi XDC Company Details
 Table 48. WuXi XDC Business Overview
 Table 49. WuXi XDC ADC Drug CDMO Service Product
 Table 50. WuXi XDC Revenue in ADC Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 51. WuXi XDC Recent Development
 Table 52. Lonza Company Details
 Table 53. Lonza Business Overview
 Table 54. Lonza ADC Drug CDMO Service Product
 Table 55. Lonza Revenue in ADC Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 56. Lonza Recent Development
 Table 57. Merck Company Details
 Table 58. Merck Business Overview
 Table 59. Merck ADC Drug CDMO Service Product
 Table 60. Merck Revenue in ADC Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 61. Merck Recent Development
 Table 62. Axplora Company Details
 Table 63. Axplora Business Overview
 Table 64. Axplora ADC Drug CDMO Service Product
 Table 65. Axplora Revenue in ADC Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 66. Axplora Recent Development
 Table 67. Catalent Company Details
 Table 68. Catalent Business Overview
 Table 69. Catalent ADC Drug CDMO Service Product
 Table 70. Catalent Revenue in ADC Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 71. Catalent Recent Development
 Table 72. Abbvie Company Details
 Table 73. Abbvie Business Overview
 Table 74. Abbvie ADC Drug CDMO Service Product
 Table 75. Abbvie Revenue in ADC Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 76. Abbvie Recent Development
 Table 77. MabPlex International Company Details
 Table 78. MabPlex International Business Overview
 Table 79. MabPlex International ADC Drug CDMO Service Product
 Table 80. MabPlex International Revenue in ADC Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 81. MabPlex International Recent Development
 Table 82. TOT Biopharm Company Details
 Table 83. TOT Biopharm Business Overview
 Table 84. TOT Biopharm ADC Drug CDMO Service Product
 Table 85. TOT Biopharm Revenue in ADC Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 86. TOT Biopharm Recent Development
 Table 87. Zencore Biologics Company Details
 Table 88. Zencore Biologics Business Overview
 Table 89. Zencore Biologics ADC Drug CDMO Service Product
 Table 90. Zencore Biologics Revenue in ADC Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 91. Zencore Biologics Recent Development
 Table 92. Healsun Biopharm Company Details
 Table 93. Healsun Biopharm Business Overview
 Table 94. Healsun Biopharm ADC Drug CDMO Service Product
 Table 95. Healsun Biopharm Revenue in ADC Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 96. Healsun Biopharm Recent Development
 Table 97. Research Programs/Design for This Report
 Table 98. Key Data Information from Secondary Sources
 Table 99. Key Data Information from Primary Sources
 Table 100. Authors List of This Report


List of Figures
 Figure 1. ADC Drug CDMO Service Picture
 Figure 2. Global ADC Drug CDMO Service Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global ADC Drug CDMO Service Market Share by Type: 2023 VS 2030
 Figure 4. Antibody Features
 Figure 5. Linker and Payload Features
 Figure 6. Other Features
 Figure 7. Global ADC Drug CDMO Service Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global ADC Drug CDMO Service Market Share by Application: 2023 VS 2030
 Figure 9. Small and Medium-sized Pharmaceutical Companies Case Studies
 Figure 10. Large Pharmaceutical Companies Case Studies
 Figure 11. ADC Drug CDMO Service Report Years Considered
 Figure 12. Global ADC Drug CDMO Service Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 13. Global ADC Drug CDMO Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global ADC Drug CDMO Service Market Share by Region: 2023 VS 2030
 Figure 15. Global ADC Drug CDMO Service Market Share by Players in 2023
 Figure 16. Global Top ADC Drug CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADC Drug CDMO Service as of 2023)
 Figure 17. The Top 10 and 5 Players Market Share by ADC Drug CDMO Service Revenue in 2023
 Figure 18. North America ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 19. North America ADC Drug CDMO Service Market Share by Country (2019-2030)
 Figure 20. United States ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Canada ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe ADC Drug CDMO Service Market Share by Country (2019-2030)
 Figure 24. Germany ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. France ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. U.K. ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Italy ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Russia ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Nordic Countries ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Asia-Pacific ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific ADC Drug CDMO Service Market Share by Region (2019-2030)
 Figure 32. China ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Japan ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. South Korea ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Southeast Asia ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. India ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Australia ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Latin America ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America ADC Drug CDMO Service Market Share by Country (2019-2030)
 Figure 40. Mexico ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Brazil ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Middle East & Africa ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa ADC Drug CDMO Service Market Share by Country (2019-2030)
 Figure 44. Turkey ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Saudi Arabia ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. UAE ADC Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. WuXi XDC Revenue Growth Rate in ADC Drug CDMO Service Business (2019-2024)
 Figure 48. Lonza Revenue Growth Rate in ADC Drug CDMO Service Business (2019-2024)
 Figure 49. Merck Revenue Growth Rate in ADC Drug CDMO Service Business (2019-2024)
 Figure 50. Axplora Revenue Growth Rate in ADC Drug CDMO Service Business (2019-2024)
 Figure 51. Catalent Revenue Growth Rate in ADC Drug CDMO Service Business (2019-2024)
 Figure 52. Abbvie Revenue Growth Rate in ADC Drug CDMO Service Business (2019-2024)
 Figure 53. MabPlex International Revenue Growth Rate in ADC Drug CDMO Service Business (2019-2024)
 Figure 54. TOT Biopharm Revenue Growth Rate in ADC Drug CDMO Service Business (2019-2024)
 Figure 55. Zencore Biologics Revenue Growth Rate in ADC Drug CDMO Service Business (2019-2024)
 Figure 56. Healsun Biopharm Revenue Growth Rate in ADC Drug CDMO Service Business (2019-2024)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart